ClinicalTrials.Veeva

Menu

Stratus Versus Cirrus OCT in AMD

T

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Status

Unknown

Conditions

Choroidal Neovascularization
Age-Related Macular Degeneration

Study type

Observational

Funder types

Other

Identifiers

NCT00568191
EK 06-007-VK1

Details and patient eligibility

About

The Cirrus OCT provides due to the spectral domain technology a 2-fold resolution than Stratus OCT generated in a comparable amount of time. Due to this higher resolution the retinal surface and the retinal pigment epithelium can be identified more clearly, a significantly reduced number of algorithm failures is expected

Enrollment

100 estimated patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>55 years
  • Age-related macular degeneration

Exclusion criteria

  • Not consented patients

Trial design

100 participants in 2 patient groups

1
Description:
retinal thickness program Stratus OCT software 4.0
2
Description:
retinal cube 200x200 program of Cirrus OCT

Trial contacts and locations

1

Loading...

Central trial contact

Ilse Krebs, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems